[Skip to Content]
[Skip to Content Landing]
Viewpoint
June 2017

Enhanced Epilepsy Surveillance and Awareness in the Age of Zika

Author Affiliations
  • 1Neuro-Infectious Diseases Group, Division of Infectious Diseases, Department of Neurology, University of Colorado Denver, Aurora
  • 2Division of Congenital and Developmental Disorders, Centers for Disease Control and Prevention, Atlanta, Georgia
  • 3Epilepsy Program, Division of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia
JAMA Neurol. 2017;74(6):631-632. doi:10.1001/jamaneurol.2017.0215

Zika virus (ZIKV) is a flavivirus transmitted primarily through the bite of an infected mosquito, through sexual activity without a condom, and probably through blood transfusion and exposure to other bodily fluids.1 Prior to 2015, ZIKV disease outbreaks occurred in areas of Africa, Southeast Asia, and the Pacific Islands. Since 2015, outbreaks have occurred in the Americas.1 In general, ZIKV infection produces no clinical symptoms in many individuals or a mild, self-limiting illness characterized by rash, fever, myalgia, arthralgia, headaches, and/or nonpurulent conjunctivitis.1

×